Integer Holdings Corporation Integer Holdings Corporation

Integer Holdings Corporation

ITGR

Rang in Aktien #3855
Integer Holdings Corporation functions as a global leader in outsourced medical... Integer Holdings Corporation functions as a global leader in outsourced medical device manufacturing, maintaining operations across the United States, Puerto Rico, Costa Rica, and other international regions. The company organizes its business into two primary divisions: Medical and Non-Medical. Within its Medical segment, Integer delivers a broad array of devices and components essential for numerous advanced medical procedures. These solutions cater to areas such as interventional cardiology, structural heart conditions, heart failure management, peripheral and neurovascular interventions, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology. Their extensive product portfolio includes cardiac rhythm management devices like implantable pacemakers, defibrillators, cardiac monitors, leads, and heart failure therapies. They also produce neuromodulation devices, such as implantable spinal cord stimulators, alongside critical components like non-rechargeable batteries, feedthroughs, device enclosures, precision-machined parts, and lead sub-assemblies. Furthermore, Integer provides rechargeable battery systems and chargers. A comprehensive range of surgical instruments and components is also offered for arthroscopic, laparoscopic, and general surgery, encompassing items like harmonic scalpels, various blades and shavers, radio frequency and biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment parts, and phacoemulsification needles. Orthopedic offerings comprise specialized instruments for hip, knee, and spine surgeries, including reamers and chisels, among other general medical technologies. The Non-Medical segment concentrates on developing customized battery power and management systems, along with specialized battery solutions, designed for the energy, military, and environmental sectors. Integer primarily collaborates with multinational original equipment manufacturers (OEMs) and their affiliated subsidiaries, supporting their requirements across diverse markets, including cardiac, neuromodulation, orthopedics, vascular, advanced surgical, and portable medical applications. Established in 1970, Integer Holdings Corporation is headquartered in Plano, Texas.
Aktienkurs
$126.70
Zuletzt synchronisiert: 2026-10-16
Marktkapitalisierung
$4.31B
Veränderung (1 Tag)
-0.02%
Veränderung (1 Jahr)
20.86%
Land
US
Handel Integer Holdings Corporation (ITGR)

Kategorie

Healthcare
Operative Marge für Integer Holdings Corporation (ITGR)
Operative Marge zum October 2026 TTM: 9.47%
Laut den neuesten Finanzberichten und dem Aktienkurs von Integer Holdings Corporation beträgt die aktuelle operative Marge (TTM) 9.47%. Am Ende des Jahres 2023 lag die operative Marge bei 10.48%.
Historie der operativen Marge von Integer Holdings Corporation von 2000 bis 2026
Operative Marge zum Jahresende
Jahr Operative Marge ändert
2026 (TTM) 9.47% -21.93%
2024 12.13% 15.74%
2023 10.48% 18.82%
2022 8.82% -20.61%
2021 11.11% -1.16%
2020 11.24% -10.30%
2019 12.53% -2.11%
2018 12.80% 34.17%
2017 9.54% 22.15%
2016 7.81% -29.00%
2015 11.00% 19.05%
2014 9.24% 131.00%
2012 4.00% -63.13%
2011 10.85% -16.09%
2010 12.93% 102.66%
2009 6.38% 1.59%
2007 6.28% -23.88%
2006 8.25% 17.86%
2005 7.00% -47.99%
2004 13.46% -15.56%
2003 15.94% -3.45%
2001 16.51% 12.08%
2000 14.73% 0.00%
Operative Marge vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Operative Marge Differenz der operativen Marge Land
17.03% -98.20%
US
17.86% -98.11%
IE
22.03% -97.67%
US
21.46% -97.73%
US
0.00% -
DE
Was ist die operative Marge eines Unternehmens?
Die operative Marge ist ein wichtiger Indikator zur Bewertung der Rentabilität eines Unternehmens. Höhere operative Margen sind in der Regel besser, da sie zeigen, dass ein Unternehmen seine Produkte oder Dienstleistungen mit deutlichem Gewinn über den Produktionskosten verkauft. Die operative Marge wird berechnet, indem der Gewinn des Unternehmens durch seinen Umsatz geteilt wird.